The FDA cleared two robotic surgical systems—Medtronic’s Hugo RAS and CMR Surgical’s Versius Plus—broadening hospital choices for robotic-assisted soft-tissue surgery. In parallel, HAI Solutions received De Novo classification for its QIKCAP System, the first FDA green light for a UVC microbial‑reduction device designed for needleless IV connectors. The approvals signal sustained regulatory receptivity for both advanced med‑tech platforms and infection‑control innovations that can be integrated into acute‑care workflows.